Talphera (TLPH) Cash from Investing Activities (2010 - 2026)
Talphera (TLPH) recorded quarterly Cash from Investing Activities of -$2.7 million in Q1 2026, down 178.21% quarter-over-quarter from $3.5 million in Q4 2025.
Talphera (TLPH) Cash from Investing Activities (2010 - 2026) Analysis & Trends
Talphera's Cash from Investing Activities history runs 17 years deep, the most recent figure standing at -$2.7 million for Q1 2026.
- In Q1 2026, Cash from Investing Activities changed N/A year-over-year to -$2.7 million; the TTM figure through Mar 2026 stood at -$17.1 million (down 362.0% YoY), while the FY2025 annual figure was -$14.3 million, down 479.4% from the prior year.
- Cash from Investing Activities was -$2.7 million for Q1 2026 at Talphera, down from $3.5 million in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $20.2 million in Q1 2022 to a low of -$17.8 million in Q3 2025.
- Historically, Cash from Investing Activities has averaged $1.7 million across 5 years, with a median of $2.7 million in 2022.
- The sharpest annual moves came in 2022 and 2025: Cash from Investing Activities surged 283.28% in 2022, then slumped 3069.17% in 2025.
- A 5-year view of Cash from Investing Activities shows it stood at $2.7 million in 2022, then tumbled by 237.26% to -$3.7 million in 2023, then soared by 116.43% to $600000.0 in 2024, then jumped by 478.33% to $3.5 million in 2025, then tumbled by 178.21% to -$2.7 million in 2026.
- The last three Cash from Investing Activities figures came in at -$2.7 million (Q1 2026), $3.5 million (Q4 2025), and -$17.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 229.00 Mn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | -87.00 Mn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 743.70 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | -506.20 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | -60.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | -2.08 Bn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 25.99 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | -15.45 Mn |
| 10 | Talphera | 56.51 Mn | 56.51 Mn | - | -2.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.71 Mn |
| Mar 31, 2026 | -2.71 Mn |
| Dec 31, 2025 | 3.47 Mn |
| Dec 31, 2025 | 3.47 Mn |
| Sep 30, 2025 | -17.82 Mn |
| Sep 30, 2025 | -17.82 Mn |
| Sep 30, 2024 | 600,000.00 |
| Sep 30, 2024 | 600,000.00 |
| Jun 30, 2024 | 5.91 Mn |
| Jun 30, 2024 | 5.91 Mn |
| Mar 31, 2024 | -2.73 Mn |
| Mar 31, 2024 | -2.73 Mn |
| Dec 31, 2023 | -3.65 Mn |
| Dec 31, 2023 | -3.65 Mn |
| Jun 30, 2023 | 2.72 Mn |
| Jun 30, 2023 | 2.72 Mn |
| Mar 31, 2023 | 400,000.00 |
| Mar 31, 2023 | 400,000.00 |
| Dec 31, 2022 | 2.66 Mn |
| Dec 31, 2022 | 2.66 Mn |